Lung Cancer in Patients with Severe Idiopathic Pulmonary Fibrosis: Critical Aspects

This study discusses advantages and disadvantages of lung cancer treatments in patients with severe IPF, highlighting several controversial aspects on this topic, including potential nintedanib treatment.

Source: In Vivo - June 24, 2017 Category: Research Authors: BARGAGLI, E., BONTI, V., FERRARI, K., ROSI, E., BINDI, A., BARTOLUCCI, M., CHIARA, M., VOLTOLINI, L. Tags: Clinical Studies Source Type: research